Search

David Nodari Surguladze

from Chatham, NJ
Age ~57
Get Report
Also known as:
David N Surguladze, Dave Surguladze, David E
Phone and address:
119 Weston Ave, Chatham Township, NJ 07928
(973) 635-0053
Related to:
Tamara Kakabadze, 59Lena SurguladzeRevaz Surguladze, 95Levan Surguladze, 66Revaz Surguladze, 37
Connected to:
Richard L Surguy, 70Christopher M Surh, 58Angela M Suri, 64Arjun S Suri, 29Chetan Suri, 52Chitra Suri, 61Cruz Suri, 34Heemanshu Suri, 35Jeremi A Suri, 52Jyoti Suri, 34

David Surguladze Phones & Addresses

  • 119 Weston Ave, Chatham, NJ 07928 (973) 635-0053
  • 515 Main St, Chatham, NJ 07928 (973) 635-0053
  • Edgewater, NJ
  • 1000 Smith Level Rd, Carrboro, NC 27510 (919) 942-9924
  • 4303 Emerald Forest Dr, Durham, NC 27713 (919) 484-8070
  • 2752 Campus Walk Ave, Durham, NC 27705
  • Morgan, NJ

Work

Position: Medical Professional

Education

Degree: High school graduate or higher

Publications

Us Patents

Anti-Flt3 Antibodies

View page
US Patent:
20090297529, Dec 3, 2009
Filed:
May 28, 2009
Appl. No.:
12/473295
Inventors:
Yiwen Li - Jersey City NJ, US
Dan Lu - Montvale NJ, US
James Robert Tonra - Skillman NJ, US
David Surguladze - Chatham NJ, US
International Classification:
A61K 39/395
C07K 16/18
C07H 21/04
C12N 15/63
C12N 5/10
C12P 21/06
US Classification:
4241391, 5303879, 536 2353, 4353201, 435325, 435 696
Abstract:
The present invention provides fully human antibodies that specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity. The invention further provides methods of treating leukemia by administering an effective amount of an antibody either alone or in combination with an anti-cancer agent or treatment including methotrexate.

Anti-Flt3 Antibodies

View page
US Patent:
20110008355, Jan 13, 2011
Filed:
Sep 27, 2010
Appl. No.:
12/890793
Inventors:
Yiwen LI - Jersey City NJ, US
Dan LU - Montvale NJ, US
James Robert TONRA - Skillman NJ, US
David SURGULADZE - Chatham NJ, US
International Classification:
A61K 39/395
C12P 21/06
C12N 5/10
C12N 15/63
C07K 16/18
C07H 21/04
A61P 35/02
A61P 35/00
US Classification:
4241391, 435 696, 435325, 4353201, 5303879, 536 2353
Abstract:
The present invention provides fully human antibodies that specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity. The invention further provides methods of treating leukemia by administering an effective amount of an antibody either alone or in combination with an anti-cancer agent or treatment including methotrexate.

Anti-Flt3 Antibodies

View page
US Patent:
20110091470, Apr 21, 2011
Filed:
May 28, 2009
Appl. No.:
12/994956
Inventors:
Yiwen Li - Jersey City NJ, US
Dan Lu - Montvale NJ, US
David Surguladze - Chatham NJ, US
James Robert Tonra - Skillman NJ, US
Assignee:
IMCLONE LLC - P.O. Box 6288 IN
International Classification:
A61K 39/395
C07K 16/18
A61P 35/00
A61P 35/02
US Classification:
4241391, 5303879, 5303917, 5303913
Abstract:
The present invention provides fully human antibodies that specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity. The invention further provides methods of treating leukemia by administering an effective amount of an antibody either alone or in combination with an anti-cancer agent or treatment including methotrexate.
Control profile
David Nodari Surguladze from Chatham, NJ, age ~57 Get Report